Martin McGlynn
2010
In 2010, Martin McGlynn earned a total compensation of $2.1M as President and CEO at StemCells, a 62% increase compared to previous year.
Compensation breakdown
| Bonus | $259,875 |
|---|---|
| Option Awards | $260,970 |
| Salary | $525,000 |
| Stock Awards | $1,050,000 |
| Other | $43,467 |
| Total | $2,139,312 |
McGlynn received $1.1M in stock awards, accounting for 49% of the total pay in 2010.
McGlynn also received $259.9K in bonus, $261K in option awards, $525K in salary and $43.5K in other compensation.
Rankings
In 2010, Martin McGlynn's compensation ranked 2,867th out of 10,439 executives tracked by ExecPay. In other words, McGlynn earned more than 72.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,867 out of 10,439 | 73rd |
Division Manufacturing | 1,004 out of 3,838 | 74th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 153 out of 672 | 77th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 76 out of 378 | 80th |
Industry Surgical and Medical Instruments and Apparatus | 41 out of 245 | 83rd |
Source: SEC filing on October 31, 2013.
McGlynn's colleagues
We found four more compensation records of executives who worked with Martin McGlynn at StemCells in 2010.